升级至高级会员解锁所有内容!

移步至“会员中心”,完善资料并上传医师执照,即可升级至高级会员权限,浏览本站所有内容,包括使用培训软件、参与大赛和培训报名等。

去上传

LCI和京都胃炎分类:可见性和评分员间可信度评估

收藏已收藏
1490
LCI文献

LCI和京都胃炎分类:可见性和评分员间可信度评估

2022/03/11LCI文献
收藏已收藏
1490
查看全文

LCI和京都胃炎分类:可见性和评分员间可信度评估

Linked Color Imaging and the Kyoto Classification of Gastritis: Evaluation of Visibility and Inter-Rater Reliability



T Takeda, D Asaoka, S Nojiri, M Nishiyama, A Ikeda… - Digestion, 2020

结 论

LCI提高了内镜检查结果的可见性,而BLI-bright提高了肠化生的可见性。


Conclusions: The visibility of each endoscopic finding was improved by LCI while that of intestinal metaplasia was improved by BLI-bright.

01

背景和研究目的

比较现症感染、既往感染和未感染幽门螺杆菌的胃黏膜白光、LCI和BLI图像。


Background and Aims: To compare white light imaging (WLI) with linked color imaging (LCI) and blue LASER imaging (BLI) in endoscopic findings of Helicobacter pylori presently infected, previously infected, and uninfected gastric mucosae for visibility and inter-rater reliability. 

02

方法

根据京都胃炎分类,使用白光、LCI和BLI-bright模式从261名患者中获取1092幅内镜图像。这些图像包括弥漫性发红、点状发红、地图样发红、斑块状发红、嵴状发红、肠化生和萎缩性边界(每个症状52个病例),由10名专家和10名实习内镜医师进行回顾性评估。医生对可见性评估如下:5(提高)、4(稍提高)、3(等效)、2(稍降低)、1(降低)。根据总分评估可见性。同时还评估了评分员间可信度。


Methods: WLI, LCI and BLI bright mode (BLI-bright) were used to obtain 1,092 endoscopic images from 261 patients according to the Kyoto Classification of Gastritis. Images were evaluated retrospectively by 10 experts and 10 trainee endoscopists and included diffuse redness, spotty redness, map-like redness, patchy redness, red streaks, intestinal metaplasia, and an atrophic border (52 cases for each finding, respectively). Physicians assessed visibility as follows: 5 (improved), 4 (somewhat improved), 3 (equivalent), 2 (somewhat decreased), and 1 (decreased). Visibility was assessed from totaled scores. The inter-rater reliability (intraclass correlation coefficient) was also evaluated. 

03

结果

所有内镜医师都报告跟白光相比,LCI能提高可见性:弥漫性发红55.8%;点状发红38.5%;地图样发红57.7%;斑块状发红40.4%;嵴状发红53.8%;肠化生LCI 42.3%,BLI-bright 80.8%;萎缩性边界46.2%。跟白光比,所有内镜医师的LCI评分员间可信度为0.73-0.87。


Results: Compared with WLI, all endoscopists reported improved visibility with LCI: 55.8% for diffuse redness; LCI: 38.5% for spotty redness; LCI: 57.7% for map-like redness; LCI: 40.4% for patchy redness; LCI: 53.8% for red streaks; LCI: 42.3% and BLI-bright: 80.8% for intestinal metaplasia; LCI: 46.2% for an atrophic border. For all endoscopists, the inter-rater reliabilities of LCI compared to WLI were 0.73–0.87.


点击查看原文



声明

富士胶片内镜世界(LIFE World)所登载的内容及其版权和使用权归作者本人与富士胶片所有。如发现会员擅自复制、更改、公开发表或其他以盈利为目的的使用,富士胶片将追究其法律责任。网站信息中涉及的治疗手技皆为术者个人针对该名患者特定体质及健康状况所采取的手法;术者对器械和药品种类的选择,也受到手术发生时间、地点等诸多因素的影响。因而相关内容及信息仅供会员参考。如盲目使用网站信息中涉及的治疗手技而发生意外,恕富士胶片及本网站对此不承担任何责任。

最新留言